ArticleDiscover oncology2025
Causal associations among albumin, C-reactive protein, body mass index, and the risk of colorectal cancer.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeA Mendelian randomization model analysis was employed to investigate the causal direction between CRP (C-reactive protein), Alb(albumin), and BMI(body mass index), as well as their impact on colorectal cancer (CRC) risk and postoperative prognosis.
methodsTwo-sample Mendelian randomization (MR) was conducted, with BMI set as the exposure variable and CRP, Alb, and CRC as the outcome variables, to determine if CRP and Alb mediate the causal relationship between BMI and CRC. Additionally, this relationship was examined using individual-level data from a retrospective cohort analysis of local cases, which included 374 incident cases of CRC.
resultsThe analysis of the mediating effect of Alb on BMI and CRC risk demonstrated that in European and East Asian populations, BMI had a promoting effect on CRC risk (OR: 1.1903 and 1.3243, p < 0.05). A positive causal relationship was observed between BMI and Alb, but the effect was opposite (OR: 0.8671 and 0.9283, p < 0.05). Alb exhibited a protective effect against CRC (OR: 0.8707 and 0.7157, p < 0.05). The mediating effect of CRP indicated that BMI in European and East Asian populations was associated with an increased risk of CRC (OR: 1.0013 and 1.3243, p < 0.05). BMI and CRP had a positive causal relationship, with consistent effects (OR: 1.4306 and 1.1008, p < 0.05). CRP had a weak, albeit unclear, protective effect on CRC risk (OR: European, 0.9985; p < 0.05, and East Asian, 0.9992; p > 0.05). Relative to the MR results, a high BMI and Alb, along with a low CRP, were observed to be associated with more prolonged overall survival (OS) in the retrospective cohort univariate analysis (HR: 0.89, 0.92, and 1.02, P < 0.05). After adjusting for Alb, the association between BMI and CRC overall survival remained significant (HR: 0.91, P < 0.05). However, upon adjustment for CRP, BMI was not found to be independently associated with overall survival in patients with CRC.
conclusionsThe findings of this study support that BMI and related factors have a causal association with the risk of colorectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.